What is the market doing?
What the tape says about SUPN
Supernus Pharmaceuticals, Inc. is +8.4% over the past year while the S&P 500 is +23%: 14 points behind the market.
+8.4%
1-year return · S&P 500 +23%
- vs 200-day average
- −8.1%
vs 200-day average · below trend, but not far
- RSI (14)
- 41
RSI (14) · neutral
- Below its 52-week high
- −21%
Below its 52-week high
Details›
- Last close2026-08-26
- $44.93
- 1 monthS&P 500 +3.7%
- −4.8%
- 1 yearS&P 500 +23%
- +8.4%
- 5 yearsS&P 500 +87%
- +68%
- vs 50-day average$46.15
- −2.6%
- 52-week high
- $57.00
- 52-week low
- $40.57
- Annualised volatility
- 37%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- −$1.8M
| Year | Return |
|---|---|
| 2026 (year to date) | −9.6% |
| 2025 | +37% |
| 2024 | +25% |
| 2023 | −19% |
| 2022 | +22% |
| 2021 | +16% |
| 2020 | +6.1% |
| 2019 | −29% |
| 2018 | −17% |
| 2017 | +58% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 6 of 10 | +5.3% |
| Feb | 10 | 4 of 10 | −2.8% |
| Mar | 10 | 5 of 10 | +3.2% |
| Apr | 10 | 6 of 10 | +2.6% |
| May | 10 | 3 of 10 | −0.79% |
| Jun | 10 | 5 of 10 | +2.2% |
| Jul | 11 | 7 of 11 | +1.2% |
| Aug | 11 | 6 of 11 | +2.7% |
| Sep | 10 | 4 of 10 | −0.99% |
| Oct | 10 | 6 of 10 | −0.79% |
| Nov | 10 | 6 of 10 | +1.1% |
| Dec | 10 | 6 of 10 | +2.1% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Drug Manufacturers - Specialty & Generic
Ranks #19 of 28 by Smart Score